| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
19,990,000 |
| Market
Cap: |
3.10(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.155 - $0.155 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Synthetic Biologics is a clinical-stage company developing therapeutics designed to prevent and treat gastrointestinal (GI) diseases. Co.'s main clinical development candidates are: SYN-004 (ribaxamase) which is designed to degrade certain commonly used intravenous beta-lactam antibiotics within the GI tract to prevent microbiome damage, Clostridioides difficile infection, overgrowth of pathogenic organisms, the emergence of antimicrobial resistance and acute graft-versus-host-disease in allogeneic hematopoietic cell transplant recipients; and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase intended to treat both local GI and systemic diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
40,000 |
240,000 |
| Total Buy Value |
$0 |
$0 |
$26,156 |
$159,974 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
7 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shallcross Steven A |
CEO and CFO |
• • – |
2023-06-07 |
4 |
B |
$0.69 |
$9,703 |
D/D |
14,000 |
250,000 |
2.81 |
- |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2023-06-06 |
4 |
B |
$0.63 |
$16,453 |
D/D |
26,000 |
236,000 |
2.81 |
- |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2023-02-10 |
4 |
B |
$1.04 |
$26,075 |
D/D |
25,000 |
210,000 |
2.81 |
- |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2023-02-02 |
4 |
B |
$0.94 |
$23,513 |
D/D |
25,000 |
185,000 |
2.81 |
- |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2023-01-25 |
4 |
B |
$0.87 |
$21,825 |
D/D |
25,000 |
160,000 |
2.81 |
- |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2023-01-20 |
4 |
B |
$0.75 |
$18,705 |
D/D |
25,000 |
135,000 |
2.81 |
- |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2022-12-29 |
4 |
B |
$0.44 |
$43,700 |
D/D |
100,000 |
110,000 |
2.81 |
- |
|
| Tufaro Francis |
Chief Operating OfficerOfficer |
• – – |
2022-03-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
806,452 |
|
-54% |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2021-05-10 |
4 |
B |
$0.49 |
$24,595 |
D/D |
50,000 |
100,000 |
2.81 |
-1% |
|
| Shallcross Steven A |
CEO and CFO |
• • – |
2019-08-23 |
4 |
B |
$0.42 |
$20,785 |
D/D |
50,000 |
50,000 |
2.81 |
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2019-04-03 |
4 |
S |
$0.65 |
$61,907 |
I/I |
(95,241) |
165,332 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2019-04-02 |
4 |
S |
$0.66 |
$9,006 |
I/I |
(13,646) |
234,493 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2019-04-01 |
4 |
S |
$0.67 |
$27,924 |
I/I |
(41,678) |
244,402 |
|
- |
|
| Kraws Jeffrey J |
Director |
– • – |
2017-03-14 |
4 |
OE |
$0.09 |
$20,590 |
D/D |
228,773 |
228,773 |
|
- |
|
| Tarriff Scott |
Director |
– • – |
2016-11-18 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
|
- |
|
| Intrexon Corp |
10% Owner |
– – • |
2015-09-02 |
4 |
B |
$3.20 |
$3,000,000 |
I/I |
937,500 |
9,613,268 |
1.5 |
- |
|
| Wolf Jeffrey Alan |
Director |
– • – |
2015-04-01 |
4 |
OE |
$0.09 |
$976 |
D/D |
10,842 |
10,842 |
|
- |
|
| Ballantyne Charles Evan |
Chief Financial Officer |
• – – |
2014-05-22 |
4 |
B |
$1.35 |
$13,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
|
|
